The Verily Study Watch will help researchers at the UNC School of Medicine and across the country collect first-in-kind data to better understand and diagnose adverse brain outcomes after trauma.
Chronic Illness, Depression, Neurology, News, Pain, Psychiatry, PTSD, Research, Trauma, Traumatic Brain Injury
UNC and NC State researchers team up to reverse TDP-43 protein aggregation, a hallmark of degenerative diseases.
The inclusion of pregnant women in Zika virus vaccine research is crucial to solving the international health crisis, according to new guidance published by UNC’s Center for Bioethics and two other universities.
Babies, Children's Health, Contagions, Fertility, Pregnancy, Research, Vaccines, Zika
A phase 2, double-blind study of the investigational medication, brexanolone, in the treatment of women with severe PPD published in The Lancet. Clinical trials are currently underway at UNC.
Brain Health, Depression, Families, Mental Health, Pregnancy, Research, Studies, Treatment, Wellness, Women's Health
A new technique from UNC School of Medicine scientists led by Nobel Prize winner Aziz Sancar reveals the genome-wide DNA damage that a major carcinogen causes.
In two previous studies, University of North Carolina researchers and colleagues linked infant brain anatomy differences to autism diagnoses at age two. Now they show differences in functional connections between brain regions at 6 months to predict autism at age two.
Autism, Brain Health, Children's Health, Mental Health, News, Publications, Research, Studies
UNC School of Medicine researchers use new imaging methods to show that running burns fat in bone marrow, with benefits for bone health. The best effect was seen in obese mice. Maya Styner, MD, was the study's lead author.
UNC Lineberger researchers led by Dan Reuland, MD, MPH, report in the Journal of the American Medical Association Internal Medicine that providing one-on-one support and customized tools for decision-making increased screening rates for patients at two community health centers in North Carolina and New Mexico.
In a pair of preclinical studies published in the journal Neuro-Oncology, researchers from UNC Lineberger and the Phoenix-based Translational Genomics Research Institute report on the genetic evolution of glioblastoma as it progresses in severity and a potential strategy to treat this often fast-growing brain cancer type. Ryan C. Miller, MD, PhD, is the study's senior author.
Findings reveal a second target for cure research. Jenny Honeycutt, PhD, a postdoctoral research associate in the division of infectious diseases, is the study's lead author.
